导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.56% | 2082/3266 |
| 近一周 | -1.78% | 1897/3690 |
| 近一月 | -1.38% | 746/3663 |
| 近一季 | -1.72% | 874/3534 |
| 近半年 | -1.38% | 1234/3357 |
| 近一年 | - | 1863/3056 |
| 近两年 | 49.26% | 1094/2167 |
| 近三年 | 33.36% | 653/1638 |
| 成立以来 | 73.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.17% 3774/4961 |
6.11% 2853/5312 |
- - |
- - |
| 2025 | 24.73% 1773/4813 |
3.47% 1081/3635 |
3.49% 1002/4076 |
15.29% 2823/4524 |
1.03% 1580/4813 |
| 2024 | 18.47% 598/3463 |
0.92% 923/2808 |
2.58% 339/3014 |
16.38% 1470/3129 |
-1.67% 1787/3463 |
| 2023 | -9.98% 1254/2656 |
1.06% 1651/2280 |
-4.64% 1231/2385 |
- 399/2515 |
-6.59% 1837/2655 |
| 2022 | -14.04% 356/2207 |
-9.88% 361/1919 |
6.99% 553/2016 |
-14.56% 1113/2113 |
4.34% 559/2208 |
| 2021 | -5.99% 989/1822 |
-0.06% 327/1255 |
0.12% 1111/1330 |
-7.39% 1048/1466 |
1.45% 928/1822 |
| 2020 | 18.45% 745/1250 |
-11.07% 815/1028 |
9.44% 793/1067 |
6.10% 877/1164 |
14.72% 256/1184 |
| 2019 | 31.87% 456/1092 |
- - |
- - |
- - |
- - |
| 2018 | -12.81% 85/834 |
- - |
- - |
- - |
- - |
| 2017 | 24.43% 125/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华夏上证50AH优选指数A VS. 长安沪深300非周期A(740101) |